Ouro Fino Saúde Animal Participações Past Earnings Performance
Past criteria checks 2/6
Ouro Fino Saúde Animal Participações's earnings have been declining at an average annual rate of -11.1%, while the Pharmaceuticals industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 9.7% per year. Ouro Fino Saúde Animal Participações's return on equity is 12.5%, and it has net margins of 9.5%.
Key information
-11.1%
Earnings growth rate
-11.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 9.7% |
| Return on equity | 12.5% |
| Net Margin | 9.5% |
| Next Earnings Update | 13 Mar 2025 |
Recent past performance updates
Recent updates
Getting In Cheap On Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Is Unlikely
Dec 19
We Think Ouro Fino Saúde Animal Participações' (BVMF:OFSA3) Healthy Earnings Might Be Conservative
Aug 15One Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Analyst Just Cut Their EPS Forecasts
May 19Is Ouro Fino Saúde Animal Participações (BVMF:OFSA3) A Risky Investment?
Dec 20These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well
Jul 28We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Can Stay On Top Of Its Debt
Feb 01Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Has A Pretty Healthy Balance Sheet
May 27Is Now The Time To Put Ouro Fino Saúde Animal Participações (BVMF:OFSA3) On Your Watchlist?
Mar 01Does Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Have A Healthy Balance Sheet?
Feb 08Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Jan 21Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Growing Earnings But Are They A Good Guide?
Jan 03
Introducing Ouro Fino Saúde Animal Participações (BVMF:OFSA3), A Stock That Climbed 42% In The Last Three Years
Dec 15Should You Be Adding Ouro Fino Saúde Animal Participações (BVMF:OFSA3) To Your Watchlist Today?
Nov 27What You Can Learn From Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) P/E
Aug 09We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Taking Some Risk With Its Debt
Jul 13Revenue & Expenses Breakdown
How Ouro Fino Saúde Animal Participações makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 959 | 91 | 269 | 60 |
| 30 Jun 24 | 940 | 54 | 268 | 52 |
| 31 Mar 24 | 954 | -34 | 269 | 55 |
| 31 Dec 23 | 943 | -50 | 274 | 60 |
| 30 Sep 23 | 985 | -23 | 327 | 20 |
| 30 Jun 23 | 1,002 | 17 | 288 | 68 |
| 31 Mar 23 | 1,006 | 111 | 288 | 69 |
| 31 Dec 22 | 1,041 | 131 | 284 | 69 |
| 30 Sep 22 | 989 | 122 | 272 | 67 |
| 30 Jun 22 | 943 | 112 | 264 | 65 |
| 31 Mar 22 | 939 | 120 | 252 | 63 |
| 31 Dec 21 | 905 | 114 | 244 | 59 |
| 30 Sep 21 | 855 | 108 | 240 | 52 |
| 30 Jun 21 | 845 | 119 | 233 | 47 |
| 31 Mar 21 | 787 | 101 | 225 | 43 |
| 31 Dec 20 | 730 | 90 | 217 | 40 |
| 30 Sep 20 | 706 | 83 | 188 | 56 |
| 30 Jun 20 | 635 | 50 | 190 | 46 |
| 31 Mar 20 | 640 | 50 | 204 | 36 |
| 31 Dec 19 | 620 | 46 | 208 | 28 |
| 30 Sep 19 | 598 | 40 | 235 | 0 |
| 30 Jun 19 | 604 | 50 | 231 | 0 |
| 31 Mar 19 | 588 | 60 | 221 | 0 |
| 31 Dec 18 | 589 | 69 | 217 | 0 |
| 30 Sep 18 | 576 | 72 | 205 | 0 |
| 30 Jun 18 | 546 | 60 | 197 | 0 |
| 31 Mar 18 | 522 | 49 | 195 | 0 |
| 31 Dec 17 | 505 | 38 | 196 | 0 |
| 30 Sep 17 | 442 | 3 | 196 | 0 |
| 30 Jun 17 | 437 | 0 | 202 | 0 |
| 31 Mar 17 | 434 | -9 | 210 | 0 |
| 31 Dec 16 | 457 | -5 | 215 | 0 |
| 30 Sep 16 | 523 | 31 | 217 | 0 |
| 30 Jun 16 | 547 | 44 | 218 | 0 |
| 31 Mar 16 | 545 | 58 | 210 | 0 |
| 31 Dec 15 | 534 | 69 | 202 | 0 |
| 30 Sep 15 | 580 | 61 | 245 | 0 |
| 30 Jun 15 | 459 | 50 | 197 | 0 |
| 31 Mar 15 | 414 | 46 | 174 | 0 |
| 31 Dec 14 | 402 | 43 | 172 | 0 |
Quality Earnings: OFSA3 has high quality earnings.
Growing Profit Margin: OFSA3 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OFSA3's earnings have declined by 11.1% per year over the past 5 years.
Accelerating Growth: OFSA3 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: OFSA3 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (8.2%).
Return on Equity
High ROE: OFSA3's Return on Equity (12.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 13:29 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ouro Fino Saúde Animal Participações S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|